Introduction
============

Diabetes mellitus is a chronic metabolic disease, characterized by hyperglycemia with disturbances of carbohydrate, protein and fat metabolism due to an absolute or relative deficiency of insulin ([@b1-vhrm-4-0893]). Type II diabetes mellitus results from a combination of defective insulin secretion and insulin resistance, almost certainly involving the insulin receptor. Diabetic nephropathy is a syndrome occurring in people with diabetes mellitus, characterized by albuminuria, hypertension, and progressive renal insufficiency ([@b19-vhrm-4-0893]).

Diabetes mellitus is one of the most prevalent diseases in the developing world and the urgency for its management is increasing as the number of cases in these countries grows each year. In 2006, according to the World Health Organization (WHO), at least 171 million people worldwide suffered from diabetes and this figure is expected to double by the year 2030 ([@b24-vhrm-4-0893]). Globally type II diabetes mellitus is the 3rd and 10th leading cause of loss of years of potential life among women and men respectively ([@b5-vhrm-4-0893]). A study done in 2001 among people 35--64 years old found that in Trinidad and Tobago, over 10% of the population had diabetes ([@b1-vhrm-4-0893]).

The red cell membrane contains approximately equal amounts of lipids and proteins. Membrane lipids are either phospholipids or neutral lipids, mostly unesterified cholesterol. Membrane phospholipids are asymmetrically arranged into a lipid bilayer two molecules thick. Choline phospholipids are more abundant in the extracellular surface whereas amino phospholipids are more concentrated on the inner leaflet of the bilayer. Cholesterol is intercalated between the phospholipid molecules. The relative amounts of cholesterol and phospholipids are responsible for the fluid properties of the erythrocyte membrane ([@b2-vhrm-4-0893]; [@b14-vhrm-4-0893]). Alterations in the membrane cholesterol-phospholipid ratio result in morphologically abnormal erythrocytes with decreased life span. Alterations in blood rheological properties have been reported in poorly controlled diabetes mellitus ([@b6-vhrm-4-0893]; [@b13-vhrm-4-0893]). Changes in lipid composition of RBC membranes resulting in an impairment of RBC deformability may play a role in an altered blood rheological pattern ([@b3-vhrm-4-0893]). There are few reports on the relationship between serum and RBC membrane lipid composition in other populations. [@b7-vhrm-4-0893] showed that diet and general health status has close relation to the flow behavior of blood, which influences the circulation of the blood in the body. In their study they demonstrated that the high level of cholesterol, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in vivo alter the morphology and flow behavior of blood cells that can subsequently increase the risk of impairing physical function and microcirculation ([@b7-vhrm-4-0893]). The present study has sought to determine and examine the relationship of the RBC membrane and serum lipid composition in Trinidadian type II diabetes with or without nephropathy (between the ages of 18--65 yrs). In addition, it has sought to determine the relationship between the RBC membrane and serum lipid composition in noninsulin-dependent diabetes mellitus (NIDDM) patients in the multiethnic population of Trinidad, a third world country in the Americas.

This study has aimed to establish a link between the lipid composition of the RBC membrane and serum to aid in the early diagnosis and treatment of patients with type II diabetes mellitus, thus preventing the development of further complications including the impaired RBC deformability.

Methods
=======

Research design and method
--------------------------

The objective of this case control study was to determine the impact of type II diabetes mellitus on RBC membrane and serum lipid composition among individuals between the ages of 18 and 65 in Trinidad. The study includes 60 subjects (male and female regardless of ethnicity) of which 20 were healthy individuals, 20 patients were type II diabetes, and 20 patients had type II diabetes and nephropathy.

The patients were recruited from the diabetic and nephrology clinic of various regional health centers of Trinidad and Tobago. The diabetics were selected on the basis of their fasting blood glucose value. The urea, creatinine, and microalbumin values were considered for including diabetic nephropathy patients in our study. The study was approved by the Ethics Committee for human experimentation (EC 59: 07/07-05/06), The Faculty of Medical Sciences, The University of the West Indies, St. Augustine. The blood pressure, height, weight (and resultant body mass index \[BMI\]), hip circumference, and waist circumference (and resultant waist/hip ratio) of all participants were recorded. Data was also collected by taking blood samples from which the following outcome attributes were measured: plasma glucose, serum total cholesterol, triglyceride (TG), LDL, HDL, RBC membrane composition (cholesterol, proteins, phospholipids, ATPase) and blood glucose.

Determination of serum lipid composition
----------------------------------------

The fasting blood sugar cholesterol, TG, HDL, and LDL cholesterol were estimated by fully automated analyzer (Vitros 250; Ortho-Clinical Diagnostics Inc., Rochester, NY, USA).

Estimation of RBC membrane compositions
---------------------------------------

### Processing of RBC

The blood collected in purple colored tube was centrifuged for 10 minutes and the supernatant (plasma) was discarded. Two mL of normal saline was added to the tubes, mixed and centrifuged at 5000 g for 10 minutes. The supernatant was decanted and this procedure was repeated twice. Then 0.1mL tris HCl buffer, pH 7.4 (isotonic) was added and centrifuged for 5 minutes. This procedure was repeated three times. The clear cells obtained were suspended in a hypotonic buffer and stored at 4 °C for four hours. Afterwards the cells were washed again with hypotonic buffer and then centrifuged at 15,000 g and 10,000 g for 30 and 20 minutes, respectively. This procedure was continued until the solution became colorless. Two drops of isotonic buffer were added to the solution and it was homogenized to get the red cell membrane. This was used for the extraction lipids and determination of protein and Na^+^K^+^ATPase estimation.

### Extraction of lipids

The red cell membrane collected was again centrifuged for 10 minutes at 15,000 g. The supernatant was decanted and the pellet obtained was suspended in 1 ml of methanol and homogenized. The solution was made up to 5 ml with the same methanol and centrifuged for 15 minutes at the same speed. The supernatant was decanted, added 14 ml of chloroform to the tube and transferred in to a flat bottom flask. The content of this flask was evaporated in a fume hood. To the evaporated content, added 5 ml of chloroform- methanol mixture to dissolve the solid and the resulting solution is poured into a labeled centrifuge tube and covered with paraffin. These tubes are centrifuged at 6000 rpm and two differed layers of fluid were visible. The upper aqueous layer was aspirated and discarded while the lower layer was retained for lipid testing ([@b9-vhrm-4-0893]). Aliquots of this layer were used for the estimation of cholesterol, phospholipids, and TG.

Membrane cholesterol
--------------------

Lipid extract of 0.6 ml was evaporated. Different standard concentrations ranging from 20, 40, 60, 80, 100, and 120 μg was used. Each standard of 0.05 mL was transferred from respective tubes to the tubes labeled S1 to S6 and evaporated. To these tubes (including the test) was added 3 ml of ferric acetate uranyl acetate. The blank was run simultaneously. Sulphuric acid ferrous sulphate 2 ml was added and the contents were mixed properly. The tubes were left standing for 20 minutes and their color intensity was read at 560 nm. The cholesterol concentration of the test sample was determined using a standard graph plotted ([@b15-vhrm-4-0893]).

Membrane phospholipids
----------------------

Lipid extract of 0.6 ml was evaporated in a fume hood. Standard phosphate solutions of five different concentrations were used. A blank was run simultaneously. To all the tubes added 1 ml of perchloric acid, 0.5 ml of 3% ammonium molybdate (freshly prepared), and 0.5 ml ascorbic acid (freshly prepared). The total volume of all the tubes was made up to 6 ml with deionised water. All tubes were kept in boiling water for 6 minutes and the blue color developed was red at 710 nm. The phospholipid concentration of the test sample was determined using a standard graph plotted ([@b17-vhrm-4-0893]).

Membrane Na^+^K^+^ATPase
------------------------

The membrane collected was used for the Na^+^K^+^ATPase. The membrane was made up to 1 ml with isotonic buffer and added 0.2 ml of 50 mM MgSO~4~, 50 mM KCl, 1 mM EDTA, and 40 mM ATP solution. Blank was run along with it which contained the entire reagent except the red cell membrane. The tubes were equilibrated at 37 °C for 10 minutes. To all the tubes added 0.1 ml of enzyme solution at intervals of 3 minutes and the tubes were incubated at 37 °C for one hr in a water bath. After one hour, 1 ml of ice cold 10% TCA and 0.1ml of ANSA was added. The blue color developed was read at 620 nm. The Na^+^K^+^ATPase concentration of the test sample was determined using a standard graph ([@b4-vhrm-4-0893]).

Membrane protein
----------------

Membrane suspension of 0.1 ml was made up to 1.0 ml with deionised water. 5.0 ml of alkaline copper reagent was added, mixed well and allowed to stand for 10 minutes at room temperature. Standards solutions of bovine serum albumin range from 10--100 μg and blank containing 1 ml water were treated similarly. Folin-Ciocalteu reagent of 0.5 ml was added very rapidly and mixed immediately. After two minutes the blue color developed was read at 640 nm. Protein concentrations were expressed in mg/ml of the membrane preparation ([@b12-vhrm-4-0893]).

Sample specification
--------------------

The target population for this study consisted of individuals between the age of eighteen to sixty five years each, regardless of gender and race residing in Trinidad. There are three groups: A -- control (healthy individuals); B -- type II diabetics without nephropathy; and C -- type II diabetics with nephropathy.

Individuals for group A were chosen from those patients screened at the diabetic clinics and proven to be healthy. Individuals for group B were chosen from those patients attending the diabetic clinics at the three previously mentioned hospitals. Individuals for group C were chosen from those patients attending the nephrology clinic at the same hospitals.

Statistics and calculations
---------------------------

Results were expressed as mean ± standard deviation. Data were analyzed using the Statistical Package for Social Science (version 12.0; SPSS Inc., Chicago, IL, USA). The sample size calculated for this study was 22 per group, however due to logistic limitations we were only able to obtain 20 samples per group and hence the sample size used was 20. The comparisons within and among groups were done using Student's paired t- test and independent samples t-test. The p value \<0.05 was taken as the cut off level for significance. Pearson's correlation test was used to examine correlation.

Results
=======

[Table 1](#t1-vhrm-4-0893){ref-type="table"} and bar diagrams show the anthropometric and biochemical values for the three groups of subjects. The body mass index and the systolic blood pressure of the diabetics (28.17 ± 4.98 kg/m^2^, 153.21 ± 22.10 mmHg) and nephropathic diabetics (25.87 ± 4.68 kg/m^2^, 158.60 ± 22.49 mmHg) were higher compared with controls (24.67 ± 5.18 kg/m^2^, 119.15 ± 13.03 mmHg). The diabetic (175.89 ± 102.73 μg/mg/protein) and diabetic nephropathy (358.80 ± 262.66 μg/mg/protein) subjects showed significantly higher levels of RBC membrane cholesterol compared with controls (132.27 ± 66.47 μg/mgprotein) ([Figure 1](#f1-vhrm-4-0893){ref-type="fig"}). The membrane phospholipids, protein and Na^+^/K^+^ATPase concentrations for controls were: (9.17 ± 9.23 μg/mgprotein, 0.94 ± 0.47 mg/mL, 0.021 ± 0.021 μmoles/ml) for diabetics: (5.31 ± 4.51 μg/mg protein, 0.65 ± 0.38 mg/mL, 0.026 ± 0.039 μmoles/ml), nephropathic diabetics: (19.67 ± 14.83 μg/mg protein, 1.19 ± 0.79 mg/mL, 0.023 ± 0.020 μmoles/ml), respectively ([Figure 2](#f2-vhrm-4-0893){ref-type="fig"}). The trend of increased serum cholesterol and decreased HDL in diabetics (206.85 ± 47.34 mg/dL, 43.45 ± 9.45 mg/dL) and those with nephropathy (209.90 ± 66.13 mg/dL, 41.60 ± 9.23 mg/dL) were compared with controls (184.50 ± 35.69 mg/dL, 48.05 ± 12.42) but were not significant as expected. The LDL cholesterol was significantly higher in diabetics (131.00 ± 35.63 mg/dL) when compared with those with nephropathy (116.40 ± 54.03 mg/dL) and the control subjects (118.70 ± 37.75 mg/dL).

The correlation between waist/hip ratio and blood pressure in diabetics and diabetics with nephropathy was not significant ([Figure 3](#f3-vhrm-4-0893){ref-type="fig"}). There was an increase in the means of serum cholesterol in diabetics and diabetics with nephropathy, however there were no significant relationship when diabetics and diabetics with nephropathy were compared to controls (p = 0.611 and p = 0.415, respectively) ([Figure 4](#f4-vhrm-4-0893){ref-type="fig"}).

The mean values of RBC membrane cholesterol showed the same increase as serum cholesterol; however the relationship for this variable between controls and diabetics is not significant (p = 0.514) whereas, the relationship for this variable between diabetics and diabetics with nephropathy is significant (p = 0.023) ([Figure 5](#f5-vhrm-4-0893){ref-type="fig"}). The RBC membrane protein mean values was lower in diabetics (0.65 ± 0.38) compared with controls and a larger value in diabetics with nephropathy (1.19 ± 0.79) compared with controls (0.94 ± 0.47). The mean reading of Na^+^/K^+^ATPase activity was higher in diabetics with nephropathy (0.023 ± 0.020) and much higher in diabetics (0.031 ± 0.039) when compared with controls (0.021 ± 0.021). The mean readings of RBC membrane phospholipids showed a decrease in diabetics (5.31 ± 4.51) but an increase in diabetics with nephropathy (19.67 ± 14.83) when compared with controls (9.17 ± 8.23).

The means of LDL showed an increase in diabetics (131.00 ± 35.63) and a decrease in diabetics with nephropathy (116.40 ± 54.03) when compared with controls (118.70 ± 37.75) ([Figure 6](#f6-vhrm-4-0893){ref-type="fig"}). The mean HDL readings decreased in diabetics (43.45 ± 9.45) and more in diabetics with nephropathy (41.60 ± 9.23) when compared with controls (48.05 ± 12.42) ([Figure 6](#f6-vhrm-4-0893){ref-type="fig"}).

Discussion
==========

The increase in body mass index and waist/hip ratio was expected since obesity is a known risk factor of diabetes. Blood pressure was also elevated in the diabetic group as compared to controls since increased blood pressure, in diabetics, is correlated with increased waist circumference. Blood pressure was elevated in diabetics with nephropathy because angiopathy of renal glomeruli is an associated pathology.

Higher serum cholesterol in diabetics than controls could be attributed to the metabolism of acetate, a precursor to cholesterol, produced in increased amounts from the catabolism of fatty acids, carbohydrates and amino acids in the diet of this group ([@b20-vhrm-4-0893]). Serum cholesterol level was further elevated in diabetics with nephropathy since hypercholesterolemia is a constant feature of nephrotic syndrome ([@b11-vhrm-4-0893]). LDL-cholesterol increased in diabetics when compared to the control subjects from less than ideal management of diabetes, including poor diet control such as high intake of saturated fats and carbohydrates without the use of statins. In the diabetics with nephropathy the lower LDL-cholesterol was thought to be due to better disease management in these patients who attend a renal clinic and receive specialist attention. Decreased HDL levels in diabetics and an even further decrease in diabetics with nephropathy can be explained by reduced action of insulin at the tissue level and therefore insulin resistance ([@b21-vhrm-4-0893]).

The increased RBC membrane cholesterol and altered phospholipid concentration in diabetics and diabetic nephropathy subjects when compared with controls may explain poor metabolic control. The increase in RBC membrane cholesterol in diabetics with and without nephropathy appears to reflect serum cholesterol.

[@b16-vhrm-4-0893] observed altered levels of RBC membrane phosholipid ratio in diabetics which could account for the impaired RBC deformability frequently reported in diabetes mellitus ([@b16-vhrm-4-0893]). Researchers also showed the relationship of altered RBC lipid composition and rheological impairment of the RBC ([@b10-vhrm-4-0893]). RBC membrane protein was decreased in diabetics when compared with controls and this could be due to damage of membrane proteins by nonenzymatic glycation ([@b18-vhrm-4-0893]; [@b22-vhrm-4-0893]). In vitro studies of researchers demonstrated the decreased lipid fluidity in diabetics caused by nonenzymatic glycation of RBC membrane proteins ([@b23-vhrm-4-0893]). RBC membrane protein was higher in the cases of diabetics with nephropathy, possibly due to the altered, healthier diets that diabetics with nephropathy are strictly advised to adhere to. Such diets would ensure that glucose levels were maintained within limits, thereby reducing RBC deformability. The decrease in membrane phospholipids in diabetics could have occurred from damage induced by nonenzymatic glycosylation of the cell membrane and subsequent loss of phospholipids from the RBC membrane ([@b8-vhrm-4-0893]). The management of diet and better disease control could have resulted in increased membrane phospholipids in the diabetics with nephropathy. [@b13-vhrm-4-0893] investigated the relationship between erythrocyte deformability, plasma lipids, lipid membrane composition, and cytosolic cations in poorly controlled type 2 diabetic patients and they concluded that in poorly controlled type 2 diabetic patients there is a link between the chemical composition and the rheological properties of erythrocytes.

Our data suggest that there is a relationship between RBC membrane and serum lipid composition in subjects with type II diabetes with and without nephropathy. This relationship shows that diet and lifestyle plays a significant role in the alterations of the lipids both in serum and RBC membrane. Diet and management of diabetes plays a significant role not only in altering the lipid profile but also preventing rheological impairment of the RBC.
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###### 

Means and standard deviations for the variables tested for controls, diabetics and diabetics with nephropathy

  Variable                         Controls(Mean ± SD) n = 20   Diabetics (Mean ± SD) n = 20   Diabetes with nephropathy(Mean ± SD) n = 20
  -------------------------------- ---------------------------- ------------------------------ ---------------------------------------------
  Body mass index (Kg/m^2^)        24.67 ± 5.18                 28.17 ± 4.98                   25.87 ± 4.68
  Waist/hip ratio                  0.85 ± 0.06                  0.87 ± 0.07                    0.91 ± 0.07
  Systolic blood pressure(mmHg)    119.15 ± 13.03               153.21 ± 22.10                 158.60 ± 22.49
  Diastolic blood pressure(mmHg)   76.80 ± 7.65                 94.93 ± 10.62                  90.30 ± 13.61
  Glucose (mg/100 mL)              83.25 ± 6.29                 120.55 ± 41.20                 105.20 ± 37.64
